Common Side Effects The most commonly reported adverse events are gastrointestinal in nature: Nausea (approximately 20-44% of participants) Diarrhea (approximately 30%) Vomiting (approximately 24%) These symptoms are typically mild to moderate in severity, tend to occur most frequently during dose escalation, and generally diminish over time as tolerance develops
Visible weight loss typically begins around week 4, with significant results appearing after reaching the higher semaglutide dosages
Vendors that make therapeutic or clinical claims describing compounds as treatments for specific conditions, showing before/after imagery, or making efficacy claims are operating outside the research-only framework that reduces regulatory exposure
"That's how we'll get real answers about prevalence and causality, which social media data alone can't provide." "These are signals, not conclusions but I do think it's always worth talking to your doctor about anything unexpected you're experiencing while on a new medication, even if you're not sure if it's related," he advised
